GGrantIndex
← Search

SUSTAINED-RELEASE MICROPARTICLE-BASED ANTIREJECTION THERAPY THROUGH ENHANCEMENT OF REGULATORY T CELLS (SMARTER) PLATFORM FOR VCA IMMUNOMODULATION

$854,983FY2021Defense Health AgencyDOD

Wake Forest University Health Sciences, Winston-Salem NC

Investigators

View source on USAspending →